Total Funding
53
46
Total FundingSeries B raised
Growth Score 53 in past quarter
-4 pts
Heat Score 46 in past quarter
-16 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
31882
NextPoint Therapeutics is a clinical-stage biotechnology company that develops therapeutics to treat cancer patients.
- Xingxing Zang: Scientific Co-Founder
- Gordon Freeman: Scientific Co-Founder
About the Company
NextPoint Therapeutics is a clinical-stage biotechnology company that develops therapeutics to treat cancer patients. The company offers immunotherapies for a validated checkpoint axis that is independent of PD-1/L1 and modulates both adaptive and innate immune systems to find and destroy cancer cells. It advances therapeutic approaches
utilizing the unique upregulation of HHLA2 in cancer as an anchor for tumor-targeting therapeutic modalities.